BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20861219)

  • 1. Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen-activated protein kinase-dependent mechanism.
    Pinton P; Braicu C; Nougayrede JP; Laffitte J; Taranu I; Oswald IP
    J Nutr; 2010 Nov; 140(11):1956-62. PubMed ID: 20861219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Activation of MAPK p44/42 Is Partially Involved in DON-Induced Disruption of the Intestinal Barrier Function and Tight Junction Network.
    Springler A; Hessenberger S; Schatzmayr G; Mayer E
    Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27618100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Deoxynivalenol and Mycotoxin Adsorbent Agents on Mitogen-Activated Protein Kinase Signaling Pathways and Inflammation-Associated Gene Expression in Porcine Intestinal Epithelial Cells.
    Yu YH; Lai YH; Hsiao FS; Cheng YH
    Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33922863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression.
    Pinton P; Nougayrède JP; Del Rio JC; Moreno C; Marin DE; Ferrier L; Bracarense AP; Kolf-Clauw M; Oswald IP
    Toxicol Appl Pharmacol; 2009 May; 237(1):41-8. PubMed ID: 19289138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxynivalenol affects in vitro intestinal epithelial cell barrier integrity through inhibition of protein synthesis.
    De Walle JV; Sergent T; Piront N; Toussaint O; Schneider YJ; Larondelle Y
    Toxicol Appl Pharmacol; 2010 Jun; 245(3):291-8. PubMed ID: 20362602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontoxic concentrations of OTA aggravate DON-induced intestinal barrier dysfunction in IPEC-J2 cells via activation of NF-κB signaling pathway.
    Ying C; Hong W; Nianhui Z; Chunlei W; Kehe H; Cuiling P
    Toxicol Lett; 2019 Sep; 311():114-124. PubMed ID: 31026484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudins regulate the intestinal barrier in response to immune mediators.
    Kinugasa T; Sakaguchi T; Gu X; Reinecker HC
    Gastroenterology; 2000 Jun; 118(6):1001-11. PubMed ID: 10833473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Glutamine Enhances Tight Junction Integrity by Activating CaMK Kinase 2-AMP-Activated Protein Kinase Signaling in Intestinal Porcine Epithelial Cells.
    Wang B; Wu Z; Ji Y; Sun K; Dai Z; Wu G
    J Nutr; 2016 Mar; 146(3):501-8. PubMed ID: 26865645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of deoxynivalenol-induced endocytosis and degradation of tight junction proteins in jejunal IPEC-J2 cells involve selective activation of the MAPK pathways.
    Li E; Horn N; Ajuwon KM
    Arch Toxicol; 2021 Jun; 95(6):2065-2079. PubMed ID: 33847777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells.
    Lipschutz JH; Li S; Arisco A; Balkovetz DF
    J Biol Chem; 2005 Feb; 280(5):3780-8. PubMed ID: 15569684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junction proteins, and mitogen-activated protein kinases.
    Pinton P; Tsybulskyy D; Lucioli J; Laffitte J; Callu P; Lyazhri F; Grosjean F; Bracarense AP; Kolf-Clauw M; Oswald IP
    Toxicol Sci; 2012 Nov; 130(1):180-90. PubMed ID: 22859312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulnerability of polarised intestinal porcine epithelial cells to mycotoxin deoxynivalenol depends on the route of application.
    Diesing AK; Nossol C; Dänicke S; Walk N; Post A; Kahlert S; Rothkötter HJ; Kluess J
    PLoS One; 2011 Feb; 6(2):e17472. PubMed ID: 21364771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARγ activation inhibits endocytosis of claudin-4 and protects against deoxynivalenol-induced intestinal barrier dysfunction in IPEC-J2 cells and weaned piglets.
    Li E; Li C; Horn N; Ajuwon KM
    Toxicol Lett; 2023 Feb; 375():8-20. PubMed ID: 36596350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus and cyclosporine A alter barrier function in renal proximal tubular cells through stimulation of ERK1/2 signaling and claudin-1 expression.
    Martin-Martin N; Ryan G; McMorrow T; Ryan MP
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F672-82. PubMed ID: 19955189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Mixture Effects of Cereulide and Deoxynivalenol on Intestinal Barrier Integrity and Uptake in Differentiated Human Caco-2 Cells.
    Beisl J; Varga E; Braun D; Warth B; Ehling-Schulz M; Del Favero G; Marko D
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33806705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK1/2 mitogen-activated protein kinase mediates downregulation of intestinal tight junction proteins in heat stress-induced IBD model in pig.
    Yong Y; Li J; Gong D; Yu T; Wu L; Hu C; Liu X; Yu Z; Ma X; Gooneratne R; Abd El-Aty AM; Chen J; Ju X
    J Therm Biol; 2021 Oct; 101():103103. PubMed ID: 34879918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7.
    Oshima T; Miwa H; Joh T
    Am J Physiol Cell Physiol; 2008 Sep; 295(3):C800-6. PubMed ID: 18667601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPA and DHA inhibit endocytosis of claudin-4 and protect against deoxynivalenol-induced intestinal barrier dysfunction through PPARγ dependent and independent pathways in jejunal IPEC-J2 cells.
    Li E; Horn N; Ajuwon KM
    Food Res Int; 2022 Jul; 157():111420. PubMed ID: 35761666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Mg(2+) regulates the tight junctional localization of claudin-16 mediated by ERK-dependent phosphorylation.
    Ikari A; Kinjo K; Atomi K; Sasaki Y; Yamazaki Y; Sugatani J
    Biochim Biophys Acta; 2010 Mar; 1798(3):415-21. PubMed ID: 19914201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells.
    Fischer A; Gluth M; Pape UF; Wiedenmann B; Theuring F; Baumgart DC
    Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G970-9. PubMed ID: 23538493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.